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Daxx, a death domain-associated protein, is implicated in
ischemic cell death. To clarify the mechanism of cell death
mediated by Daxx, a yeast two-hybrid assay was performed.
Sodiumhydrogen exchanger isoform1 (NHE1)was identified as
a Daxx-interacting protein. During ischemic stress, Daxx trans-
locates from the nucleus to the cytoplasm, where it colocalizes
withNHE1. Daxx binds to the ezrin/radixin/moesin-interacting
domain of NHE1, in competition with ezrin. Consistent with
this finding, transfection of the constitutively cytoplasmic
mutant, Daxx(W621A), inhibited ezrin-mediated Akt-1 activa-
tion. Moreover, transfection of Daxx(W621A), but not the
Daxx(S667A) mutant that is confined to the nucleus, acceler-
ated pHi recovery from an acid load, indicating that the cyto-
plasmic protein activates NHE1. Based on the results, we pro-
pose that ischemic insult triggers the nucleocytoplasmic
translocation of Daxx, following which cytoplasmic Daxx
stimulates the NHE1 transporter activity and suppresses acti-
vation of the NHE1-ezrin-Akt-1 pathway. Our data support a
novel molecular function of Daxx as an upstream regulator of
NHE1 in ischemic cell death.
Daxx was initially identified as an interacting protein with
the cytoplasmic domain of Fas that potentiates Fas-induced cell
death as a signal transducer (1). Daxx activates the apoptosis
signal-regulating kinase 1 3 c-Jun N-terminal kinase (JNK)4
pathway upon glucose deprivation (2, 3). In addition to its func-
tion as a signal transducer in the cytoplasm, the presence of
Daxx in the nucleus has been reported. Specifically, Daxx local-
izes in the promyelocytic leukemia protein and STAT-3nuclear
bodies (4–9) and exerts strong transcriptional repression (4, 5,
7, 10–14). This discrepancy in the observed subcellular local-
ization of Daxx may be attributed to nucleocytoplasmic trans-
location, which occurs following Fas stimulation (15), heat
shock (16), oxidative stress (17), and ischemic insult (18, 19).
Daxx is involved in stress-induced cell death (16–20). How-
ever, the issue of whether Daxx promotes or prevents cell death
is currently unresolved. Depletion of Daxx with small interfer-
ing RNAs protected cells from interferon - and As2O3-in-
duced death (21), supporting its role as a death-promoting pro-
tein. Furthermore, Daxx overexpression potentiates apoptosis
induced by Fas and transforming growth factor- (1, 22). How-
ever, the view that Daxx is a death-promoting protein has often
been challenged. For instance, Daxx knockout embryos display
early embryonic lethality and extensive apoptosis (23). More-
over, Daxx silencing sensitizes cells to Fas-, UV-, and tumor
necrosis factor--induced cell death (13, 24). It is possible that
Daxx performs bipartite functions, depending on the situation.
Sodium hydrogen exchanger (NHE) exchanges one intracel-
lularH ion for an extracellularNa ion (25). NHE1, the first to
be cloned among the nine NHE isoforms (26), is ubiquitously
expressed in various cell types, and acts as a “housekeeping”
protein involved in themaintenance of pHhomeostasis and cell
volume regulation. The N terminus contains 12 transmem-
brane domains and retains ion exchange activity, whereas the C
terminus modulates NHE1 activity through phosphorylation
and binding to other proteins. The C-terminal region of NHE1
is phosphorylated by p90RSK, Nck-interacting kinase, protein
kinases A and C, p160ROCK, and p38 (27–31). Interactions
with proteins devoid of kinase activity have additionally been
reported. Calcineurin homologous protein and tescalcin bind
to NHE1 and inhibit the transporter (32–34), whereas binding
of carbonic anhydrase II and calmodulin activates NHE1 (35–
37). Moreover, NHE1 participates in cell signaling. Studies
show that NHE1 binds to the ezrin/radixin/moesin (ERM)
complex (38, 39) and activates the ERM3 PI3K3 Akt path-
way (40–42).
NHE1 involvement in ischemic damage is evident in cardiac
myocytes and primary neurons (43–48). Following intracellu-
lar acidosis during ischemia (49), NHE1 activationmay be ben-
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eficial in restoring the intracellular pH by extruding H to a
certain extent (50, 51). However, overstimulation of NHE1
enhances the intracellular Na concentration, which, in turn,
reverses the driving force for the Na/Ca2 exchanger, result-
ing in elevation of intracellular Ca2. This excessive Ca2
influx leads to cell death (52). In fact, NHE1/ neurons exhibit
resistance to ischemia, both in vitro and in vivo (53). Pharma-
cological inhibitors against NHE1 are currently under develop-
ment for therapeutic use under the premise that suppression of
NHE1 would interrupt intracellular Ca2 elevation and pro-
tects cells upon ischemic insult (54).
In the present study, we elucidate the molecular mechanism
of Daxx-mediated cell death during ischemic insult. NHE1 is
identified as a Daxx-interacting molecule. Our results demon-
strate that the nucleocytoplasmic translocation of Daxx facili-
tates a death-promoting role through activation of the NHE1
transporter and suppression of NHE1-associated Akt-1 activity
under conditions of ischemic stress.
EXPERIMENTAL PROCEDURES
Plasmid Constructions—LexA/Daxx constructs were gener-
ated using a human HeLa cDNA library as a template and PCR
primers containing EcoRI and XhoI restriction sites as previ-
ously described (55). The generated fragmentswere cloned into
the EcoRI/XhoI restriction sites of pLexA in-frame with the
LexA DNA-binding domain. The pFlag/Daxx(W621A) and
pFlag/Daxx(S667A) constructs were kindly provided by Drs.
Song and Lee (University of Pittsburgh, Pittsburgh, PA). Plas-
mids encoding glutathione S-transferase (GST)-Daxx fusion
proteins and Daxx deletion fragments (amino acids 1–130,
131–400, 400–500, 500–625, and 625–740) were generated by
PCR from full-length Daxx, followed by cloning into pGEX-
4T-1 vector (AmershamBiosciences). TheNHE1 deletion frag-
ments (cytoplasmic domain (cd) (amino acids 503–815), cal-
cineurin homologous protein (CHP)-binding domain (amino
acids 503–567), ERM-binding domain (amino acids 567–637),
calmodulin-binding domain (amino acids 637–691), and
kinase domain (amino acids 691–815)) were generated by PCR
using the primers having restriction enzyme sites at the flank-
ing sides (5, EcoRI; 3, XhoI) and cloned into EcoRI/XhoI-cut
pGEX-4T-1. GST fusion proteins were purified by affinity
chromatography using glutathione-Sepharose 4B (Peptron
Inc., Daejeon, Korea). Full-length NHE1 and Daxx cDNA
sequences were cloned into pcDNA3 vector (Invitrogen). Full-
length ezrinwas ligatedwithin the EcoRI/XhoI sites of pcDNA3
(Invitrogen Inc.).
Yeast Two-hybrid Screening—pLexA/Daxx was used to
screen a human HeLa cDNA library (Clontech, Palo Alto, CA).
The bait plasmid was introduced into the yeast strain, EGY48,
using the lithium acetate-mediated method. Yeast expressing
the bait protein was sequentially transformed with a human
HeLa cDNA library constructed in pB42AD (Clontech) and
plated on Synthetic drop-out agar deficient in leucine, trypto-
phan, and histidine. Approximately 5.5 105 transformants of
the EGY48 strain were screened using the manufacturer’s pro-
tocols. In general, colonies grew in 3–6 days and were screened
for -galactosidase activity. Library plasmids from strongly
interacting clones were isolated and retransformed into the
reporter strain to examine for interactions with Daxx, along
with positive or negative control baits.
Cell Culture and DNATransfection—Parental Chinese ham-
ster lung fibroblast CCL39, NHE-deficient PS120 (50), NHE1-
expressing PS120/NHE1 (56), BOSC23 andHeLa cell lineswere
maintained in Dulbecco’s modified Eagle’s medium supple-
mented with 10% heat-inactivated fetal bovine serum (Invitro-
gen), 1% antibiotics (penicillin/streptomycin) at 37 °C in a
humidified atmosphere of 95% air and 5% CO2. PS120/NHE1
cells (1  106) were seeded at 50% confluence onto 60-mm
dishes 24 h prior to transfection. Next, cells were transfected
with 2 g of plasmid DNA using METAFECTENE (Biontex,
Munich, Germany), according to themanufacturer’s protocols.
After 3 h of incubation with DNA-lipid complexes, cells were
refed with serum-containing medium. BOSC23 cells (1 106)
were pre-cultured for 12 h and subsequently transfected with
the indicated plasmids, using the calcium phosphate method.
Transiently transfected cells were harvested after 48 h.
Simulations of Ischemia—To induce conditions of chemical
hypoxia (CH), cells were washed once with phosphate-buffered
saline (PBS) and placed in the metabolic inhibition buffer (106
mMNaCl, 4.4mMKCl, 1mMMgCl26H2O, 38mMNaHCO3, 2.5
mM CaCl2, 20 mM 2-deoxy-D-glucose, 1 mM NaCN, pH 6.6) for
the indicated time periods (57). For glucose deprivation, cells
were exposed to glucose-free medium for 2 h and split (1:5) at
80–90% confluence. In the case of using an anaerobic chamber,
cells were incubated in serum-free, glucose-free Dulbecco’s
modified Eagle’s medium using an anaerobic chamber (Forma
Scientific, Marietta, OH) at 37 °C with 5% CO2, 10% H2, and
85% N2 (19).
In Vitro Binding of Daxx with NHE1—To analyze the inter-
actions between Daxx with NHE1, GST fusion proteins were
expressed in Escherichia coli BL21(DE3) induced with isopro-
pyl--D-thiogalactopyranoside. Subsequently, cells were soni-
cated in ice-cold lysis buffer (200 mM Tris-Cl, pH 8.0, 0.5 M
NaCl, 100 M EDTA, 0.1% Triton X-100, 0.4 mM phenylmeth-
ylsulfonyl fluoride). GST fusion proteins were incubated with
glutathione-coated beads for 4 h at 4 °C and normalized for the
protein concentration. pcDNA3/Daxx and pcDNA3/NHE1cd
were translated in vitro with TNT Quick Coupled Transcrip-
tion/Translation Systems (Promega Corp., Madison, WI).
Briefly, 2 g of DNA was incubated with 10 Ci of [35S]methi-
onine in TNT Quick Master mix for 90 min at 30 °C. In vitro
translated products were mixed with GST-fused proteins
bound to glutathione-coated beads in E1A binding buffer (50
mM HEPES, pH 7.6, 50 mM NaCl, 5 mM EDTA, 0.1% Nonidet
P-40, 10% glycerol), and incubated for 4 h at 4 °C. After washing
three times in E1A binding buffer, samples were treated with
SDS-sample buffer. Subsequently, samples were subjected to
SDS-PAGE, and analyzed by autoradiography.
In Vitro Competition Assay—GST-NHE1cd and GST-Daxx-
(1–400) fusion proteins were purified from bacteria using glu-
tathione-Sepharose. Ezrin (10 l, 35S-labeled) was incubated
with resin-bound GST-NHE1cd in the presence of non-iso-
tope-labeled Daxx at the indicated volumes for 4 h at 4 °C. The
resins were washed with E1A binding buffer, boiled in sample
buffer, and analyzed by SDS-PAGE. In another competition
experiment, 10 l of 35S-labeled NHE1cd was incubated with
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resin-bound GST-Daxx-(1–400) in the presence of non-iso-
tope labeled ezrin, as described above.
Immunoprecipitation and Western Analysis—Cells were
washed with PBS, lysed inmammalian lysis buffer (50mMTris-
Cl, pH8.0, 150mMNaCl, 1mMEDTA, 1%Nonidet P-40, 0.4mM
phenylmethylsulfonyl fluoride), sonicated, and centrifuged at
13,000 rpm for 10min. For the immunoprecipitation assay, cell
lysates were incubated for 4 h at 4 °C with anti-Daxx (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA) or anti-NHE1 anti-
bodies (58) coupled to the protein A/G-agarose beads (Santa
Cruz Biotechnology). A monoclonal M3-anti-FLAG antibody
preconjugated to agarose beads was used to immunoprecipitate
FLAG-tagged proteins. Immunoprecipitated beads were washed
three times with mammalian lysis buffer. Immunoprecipitates
and whole cell lysates were subjected to an SDS-PAGE, sepa-
rated, and transferred to a nitrocellulosemembrane. Blots were
probed overnight with the appropriate dilutions of primary
antibodies at 4 °C.Membranes were incubated with the respec-
tive horseradish peroxidase-conjugated secondary antibodies
(1:1000 dilution).Membranes were washed and developedwith
ECL plus Western blotting detection reagents.
Intracellular pH Measurement—Na/H exchange activity
was measured using a standard protocol with some modifica-
tions (59, 60). Briefly, transfected cells grownon glass coverslips
were loaded with a pH-sensitive fluorescent dye, 2,7-bis-
(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethyl
ester (BCECF-AM), and intracellular pH (pHi) changes were
measured. BCECF fluorescence was recorded at excitation
wavelengths of 440 and 490 nm using the recording setup
(Delta Ram, PTI Inc., Brunswick, NJ). Cells were acidified with
anNH4 (20mM) pulse and subsequent perfusionwithNa-free
solution.Maximal Na-dependent pHi recovery wasmeasured
in cells acidified to a pH of 6.4–6.5. The standard perfusion
solution contained (in mM): 140 NaCl, 5 KCl, 1MgCl2, 1 CaCl2,
10 glucose, and 10 HEPES (pH 7.4 with NaOH). Na-free solu-
tions were prepared by replacing Na with N-methyl-D-gluca-
mine. The osmolarity of all solutions was adjusted to 310 mM
with themajor salt. Buffer capacitywas calculated bymeasuring
pHi in response to 5–20mMNH4Cl pulses. In each experiment,
the intrinsic buffer capacity (i) displayed a negative linear rela-
tionshipwith pHi between 6.4 and 7.3. Thei of PS120 cells was
34.1 3.9mMNH4/pHunit at pHi 7.0.However, none of the
gene alterations significantly altered i. NHE1 activity is
expressed as pH/min. This value was directly analyzed with-
out compensating for i.
Immunofluorescence—For analysis of the subcellular local-
ization of Daxx upon ischemic insult, PS120/NHE1 cells were
plated on sterile coverslips in 6-well plates. After CH treatment,
cells were fixed in 3.7% formaldehyde for 15 min and 1 PBS,
incubatedwith anti-Daxx (SantaCruz Biotechnology) and anti-
NHE1 antibodies (BDBiosciences, Boston,MA) for 45min, and
washed twice with 1 PBS, followed by treatment with second-
ary antibodies for 30min. Cells were rewashed three times with
1 PBS, and mounted on slides. For determining the cellular
localization of Daxx and NHE1, PS120/NHE1 cells transfected
with FLAG-tagged Daxx mutants were plated on a coverslip.
Next, cells were fixed in 3.7% formaldehyde for 15 min and
rinsed with 1 PBS. The cells were then incubated with anti-
FLAG (Sigma) and anti-NHE1 antibodies for 1 h, washed twice
with 1 PBS, and treated with the respective secondary anti-
bodies conjugated to fluorescein isothiocyanate and TRITC
(Sigma), for 30 min. After mounting on slides, color images of
cells were acquired using an inverted Zeiss LSM510 META
confocal microscope (Carl Zeiss, Jena, Germany).
Measurement of Cell Death—The 4,6-diamidino-2-phenyl-
indole staining protocolwasmodified slightly, as described pre-
viously (61). Cells were grown on coverslips in 6-well culture
plates. Fixed cells were permeabilized with 0.5% Triton X-100
in PBS for 15 min, stained with 2 g/ml of 4,6-diamidino-2-
phenylindole, and counted under a fluorescent microscope. A
differential interference contrast (DIC) optical microscope was
used to record the images of cells with a charge-coupled device
camera (Axiocam MRm, Carl Zeiss) attached to a Zeiss Axio-
vert microscope. The cytotoxicity was assessed by monitoring
lactate dehydrogenase activity in the extracellularmedium. lac-
tate dehydrogenase was measured colorimetrically according
to the manufacturer’s instruction (Promega). The percent lac-
tate dehydrogenase was calculated from the maximum lactate
dehydrogenase release (100%) induced by lysing cells with 0.1%
Triton X-100.
RESULTS
Identification of NHE1 as aDaxx-binding Protein—To clarify
the mechanism of Daxx action in ischemic cell death, a HeLa
cDNA library was screened with the yeast two-hybrid system
utilizingDaxx as bait. Positive cloneswere selected based on the
expressions of -galactosidase reporter and leu genes, which
allowed growth on leucine-deficient plates. DNA sequencing
and subsequent GenBankTM searches revealed that three
strongly positive clones contained partial sequences of NHE1.
Accordingly, NHE1 was selected for further study (data not
shown).
The in vitro translated cytoplasmic domain of NHE1
(NHE1cd) interacted with the GST-Daxx fusion protein, but
not GST alone (Fig. 1A, left). In vitro translated Daxx addition-
ally bound to GST-NHE1cd (Fig. 1A, right). This association
between NHE1 and Daxx was confirmed by coimmunoprecipi-
tation of NHE1 with FLAG-tagged Daxx transfected in
BOSC23 cells (supplemental Fig. S1). Our results clearly indi-
cate that Daxx can physically associate with NHE1.
To determine the binding domains in NHE1-Daxx interac-
tions, GST fusions of various deletion mutants of both NHE1
andDaxx were generated (Fig. 1B). In vitro translated Daxx was
incubated with GST-NHE1 mutants (Fig. 1B, left panel). Daxx
bound toNHE1-ERM, but notNHE1-CHP,NHE1-calmodulin,
or NHE1-kinase domains. Moreover, in vitro translated NHE1
was incubated with GST-Daxx mutants (Fig. 1B, right panel).
Interaction analyses revealed that amino acids 1–400 of Daxx
associate withNHE1 (Fig. 1B, right panel). Endogenous binding
was investigated in PS120/NHE1 cells stably transfected with
cDNA encoding NHE1 with two experimental simulations of
ischemia, CH, and glucose deprivation (Fig. 1C). NHE1-Daxx
association in quiescent cells was weak, butmarkedly enhanced
in cells stimulatedwithCHor deprived of glucose. Similarly, we
observed increased NHE1-Daxx association upon CH and glu-
cose deprivation in HeLa cells (supplemental Fig. S2).
NHE1-Daxx Interactions upon Ischemic Insult
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Nuclear Export of Daxx and Subsequent Colocalization with
NHE1 under CH Conditions—We examined the subcellular
localization of NHE1 and Daxx upon ischemic stimulation
under a confocal microscope. Time-course immunofluores-
cence confocal microscopy revealed that the presence of NHE1
in the cytoplasm and nuclear envelope (Fig. 2A, second row). In
contrast, Daxx appeared as nuclear speckles in resting PS120/
NHE1 cells. However, following CH, the majority of Daxx was
exported to the cytoplasm of PS120/NHE1 cells (Fig. 2A, top
row) colocalizing with NHE1 (Fig. 2A, third row). The graphs
represent fluorescence distributions determined for cell sec-
tions (Fig. 2A, bottom row).
To analyze the correlation
between Daxx trafficking and its
colocalization with NHE1, two
Daxxmutants with different subcel-
lular destinations were employed.
FLAG-tagged Daxx(W621A) (18),
a mutant that is constitutively
expressed in the cytoplasm, was
transfected into PS120/NHE1 cells.
Daxx(W621A) colocalized with
NHE1 in the cytoplasm in the
absence of CH (Fig. 2B). Conversely,
the Daxx(S667A) mutant that is
confined to the nucleus did not
colocalize with NHE1 (Fig. 2B).
These data indicate that the subcel-
lular localization of Daxx influences
Daxx-NHE1 interactions.
Cytoplasmic Daxx Activates the
NHE1 Transporter—To establish
the physiological implications of
NHE1-Daxx binding, we overex-
pressed Daxx(W621A) in PS120/
NHE1 cells and measured NHE1
activity by determining the rate of
intracellular pH recovery from an
NH4Cl-induced acid load (60).
NHE1 restores the intracellular pH
(pHi) by extruding protons, and
alkalinizes cells (62). The intracellu-
lar pH recovery after acid load in
Daxx(W621A)-transfected cells was
more rapid than that in mock trans-
fected cells, indicating that
Daxx(W621A) stimulates NHE1 to
extrudeH (Fig. 3A). TheH trans-
port rate in Daxx(W621A)-trans-
fected cells was enhanced to 166 
28%, compared with that in mock
transfected cells. In contrast, trans-
fection with Daxx(S667A) failed to
potentiate NHE1 activity. The pHi
change was abolished in the pres-
ence of theNHE1-specific inhibitor,
cariporide, signifying that pHi is
caused by NHE1 activation (sum-
marized in Fig. 3B). Thus, it appears that direct interactions
with Daxx are required to activate NHE1.
Daxx Competes with ERM for Binding to NHE1—Because
both Daxx and ERM bind to positions 567–637 of NHE1, we
examined whether the two proteins compete for interactions
with NHE1 (Fig. 1B and supplemental Fig. S3). NHE1-ERM
interactions tether NHE1 to the actin cytoskeleton, leading to
activation of the PI3K/Akt-1 signaling pathway (38, 39, 63).
The interaction profiles of Daxx, ERM, and NHE1 in
response to CH were analyzed using immunoprecipitation
assays. Consistent with previous data (38), major interactions
were observed between positions 567–637 of NHE1 and in
FIGURE 1. Daxx interacts with NHE1. A, in vitro translated 35S-labeled products were incubated with GST,
GST-Daxx, or GST-NHE1cd (amino acids 503–815) immobilized on glutathione-Sepharose beads for 4 h. 35S-
Labeledboundproteinswere elutedwith SDS sample buffer and separatedby SDS-PAGE for autoradiography.
B, to identify the region of NHE1 interacting with Daxx, in vitro translated 35S-labeled Daxx and NHE1cd-
truncatedmutants fused to GSTwere incubated (left panel). Conversely, 35S-labeled NHE1was incubatedwith
GST-Daxx deletion mutants (right panel). Upper panels, schematic drawing of NHE1cd and Daxx mutant con-
structs. Coomassie Brilliant Blue-stained GST fusion proteins from the same gel were aligned to estimate
protein levels. C, PS120/NHE1 cells were subjected to with CH (90 min, left panel) or glucose deprivation (120
min, right panel). Endogenous Daxx was immunoprecipitated with anti-Daxx or control antibody from PS120/
NHE1 cell lysates. Immunoprecipitates were subjected to Western blotting, and blots were probed with anti-
NHE1 or anti-Daxx antibody. Whole cell lysates were immunoblotted with anti-NHE1, anti-Daxx, and anti--
tubulin antibodies. -Tubulin was used to confirm the amount of protein loaded in each lane. AD, acid-rich
domain; SPT, Ser/Pro/Thr-rich domain; PAH, paired amphipathic  helices domain; WCL, whole cell lysate; IP,
immunoprecipitation.
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vitro translated ezrin (supplemental Fig. S3). However, ezrin
bound weakly to the NHE1-CHP domain under our experi-
mental conditions (supplemental Fig. S3). ERMbound toNHE1
in quiescent cells (Fig. 4A). After exposure to CH, NHE1 disso-
ciated from ERM, and association of NHE1 with Daxx was
increased in PS120/NHE1 cells.
Similar binding patterns were
observed in HeLa cells (supplemen-
tal Fig. S4). To elucidate whether
Daxx plays a causative role in the
dissociation of ERM fromNHE1,we
examined whether addition of a
cytoplasmic Daxx mutant (W621A)
prevents ERM-NHE1 association.
Transfection of FLAG-tagged
Daxx(W621A) significantly dis-
rupted NHE1-ERM binding with-
out CH (Fig. 4B).
To further confirm the competi-
tion between Daxx and ERM for
NHE1 binding, we performed an in
vitro protein binding competition
assay. Upon incubation of GST-
NHE1cd with 35S-labeled ezrin and
increasing amounts of non-labeled
Daxx, a dose-dependent decrease in
interactions between NHE1cd and
ezrin was evident (Fig. 4C). We
additionally used GST-Daxx-(1–
400) to pull down 35S-labeled
NHE1cd mixed with increasing
amounts of non-labeled ezrin.
Ezrin inhibited NHE1-Daxx inter-
actions in a dose-dependent man-
ner (supplemental Fig. S5). Our
results clearly indicate that Daxx
and ERM compete for binding to
NHE1.
To establish whether Daxx regu-
lates NHE1-ERM-dependent Akt-1
activation, PS120/NHE1 cells were
exposed to CH, and lysates probed
for Akt-1 activity with an anti-phos-
pho-Akt-1 antibody. The extent of
Akt-1 phosphorylation declined in a
time-dependent manner (Fig. 4D,
upper panel), and Akt-1 activity
was dramatically suppressed 2 h
after CH. Consequently, the Akt-1
phosphorylation experiment was
performed 2 h after CH. Akt-1
phosphorylation was enhanced in
ezrin-transfected cells, whereas
Daxx(W621A)-transfected cells
exhibited significantly lower Akt-1
phosphorylation (Fig. 4D, lower
panel). Accordingly, we propose
that cytoplasmic Daxx blocks the
ERM-mediated cell survival pathway involving Akt-1.
NHE1-Daxx Interactions Mediate CH-induced Cell Death—
Excessive NHE1 activation in response to ischemic insult leads
to cell death (48). Thus, we examined whether Daxx-NHE1
interactions that activate NHE1 sensitize cells to ischemic
FIGURE2.NHE1-Daxx interactionsoccur followingDaxxnuclear export.A, PS120/NHE1 cellswere exposed
toCH for the indicatedperiods of time. Representative confocal images andquantitative analysis of subcellular
proteindistribution (bottom row) fromPS120/NHE1 cells after CHat the indicated times. Theoverlay represents
a fusion image of green (Daxx) and red (NHE1) fluorescence. Yellow reflects colocalization of Daxx and NHE1.
B, after 48 hof transfectionwith the indicatedplasmids, transfected cellswere stainedwith anti-FLAGantibody
(green) and anti-NHE1 (red). The graphs represent fluorescence distribution determined for cell sections, as
indicated in the green/red fusion image.  and  signify the orientation of the section. All panels show repre-
sentatives of three independent experiments.MOCK, vector only.
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insult. CH stimulation killed 25.5  1.4% of cells (Fig. 5A, left
panel). Daxx(W621A) transfection without CH additionally
caused significant cell death (19.6  0.1%). Cariporide pro-
tected cells from death induced by CH and Daxx(W621A)
transfection. This significant protection by cariporide implies
that cell death induced by both CH andDaxx(W621A) is attrib-
uted mainly to NHE1 ion transporter activity. Daxx(S667A)
transfection protected cells from CH-induced death, implying
that the cytoplasmic protein is essential for cell death. We fur-
ther investigated CH-induced death in the NHE-deficient
PS120 cells. As shown in Fig. 5A (right panel), NHE-deficient
PS120 cells were significantly resistant to CH.Moreover, trans-
fection of Daxx(W621A) failed to induce cell death. Represent-
ative DIC images of cells were obtained using an inverted
microscope equipped with DIC optics (Fig. 5B). Transfected
cells were incubated with cariporide for 30min before and dur-
ing CH. Notably, CH- and Daxx(W621A)-induced cell death
were inhibited by cariporide. Comparable sensitization and
protection in response to CH were observed in relation to the
data described for Fig. 5A. Changes in cellularmorphologywere
still evident, even in the presence of cariporide. As an additional
method of assessing the cell death, cell cytotoxicity was ana-
lyzed by lactate dehydrogenase assay following CH (supple-
mental Fig. S6). Similar sensitization to CH was observed in
cells transfected with Daxx(W621A). Also to simulate in
another manner, cells were incubated in serum-free, glucose-
free Dulbecco’s modified Eagle’s medium in an anaerobic
chamber for the indicated time periods. Similar results were
obtained (supplemental Fig. S7). Our data clearly demonstrate
that the association of NHE1 and Daxx sensitizes cells to ische-
mic stress.
DISCUSSION
This study reports molecular
interactions between Daxx and
NHE1 in response to ischemic dam-
age. Interactions between Daxx and
NHE1 lead to the elevation of the
NHE1-mediated H transport rate,
which eventually increases the
intracellular Ca2 level, resulting in
cell death. In addition, Daxx inhibits
binding of ERM to NHE1 and sup-
presses activation of the ERM 3
PI3K3Akt-1 pathway. Using Daxx
mutants with defined subcellular
localizations, we demonstrate that
trafficking of the protein deter-
mines two key cellular effects. Cyto-
plasmic Daxx appears to play a
death-promoting role, specifically,
excessive stimulation of NHE1
activity, and suppression of the cell
survival factor, Akt-1, through com-
petitive binding with ERM to NHE1
protein.
The C-terminal region of Daxx
interacts with various proteins,
including Fas (1), transforming
growth factor- (22), PML (6), Sentrin (64), Ubc-9 (55), Pax3
(10), Ets-1 (11), and several other transcription factors (65). In
addition, the nuclear proteins, X-linked -thalassaemia mental
retardation and signal transducer and activator of transcription
3 (STAT-3), interact with the N terminus of Daxx (9, 66, 67).
NHE1 displays more elaborately regulated interaction patterns
than the other Daxx-binding partners. First, Daxx-NHE1 inter-
actions are induced in response to cellular energy restriction,
and second, nucleocytoplasmic translocation of Daxx is
required for these interactions.
A recent study by our group showed that the cytoplasmic
presence of Daxx is essential for cell death upon ischemic insult
(19). In this investigation, we present preliminary evidence that
NHE1 participates in ischemic cell deathmediated by cytoplas-
mic Daxx. In particular, the finding that cariporide protects
against cell death induced by cytoplasmic Daxx implies that
NHE1 is an essential mediator of this process. The lack of cell
death by overexpression of cytoplasmic Daxx inNHE-defective
PS120 cells further confirms the pivotal role of NHE1.
We demonstrate that Daxx is a novel positive regulator of
NHE1 activity. Previously known activators ofNHE1 aremostly
kinases, such as mitogen-activated protein kinase ERK1/2 (68),
p160ROCK (28), p90RSK (29), and p38 (30), which stimulate
NHE1 activity. In view of the importance of NHE1 phosphoryl-
ation for its activation, it is possible that interactions with Daxx
facilitate phosphorylation by the above kinases. However, fur-
ther experiments are required to explore this hypothesis.
NHE1-null cells are more sensitive to death than their wild-
type counterparts (69, 70), suggesting a positive role for NHE1
in cell survival. Moreover, interactions between NHE1 and
FIGURE 3. Cytoplasmic Daxx activates NHE1. A, PS120/NHE1 cells were transfected with the mock vector,
Daxx(W621A), and Daxx(S667A), respectively. After 24 h of transfection, PS120/NHE1 cells were grown to
subconfluence on coverslips. The rate of Na/H exchangewasmeasured by determining the rate of intracel-
lular pH (pHi) recovery after an acute NH4Cl-induced acid load using BCECF-AM. B, H
 efflux rates were calcu-
lated at various pHi. Cells were treated with vehicle or 100 nM cariporide before measurement of the Na
/H
exchange rate. Cari, cariporide.
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ERM proteins are required for ERM-mediated cell survival sig-
naling (39). Cytoplasmic Daxx prevents NHE1-ERM interac-
tions and suppresses ERM-mediated Akt-1 signaling. There-
fore, cytoplasmic Daxx seems to accomplish efficient cell death
by lowering the cell survival potential in addition to enhancing
NHE1 activity. Given the diversity of the Daxx-interacting pro-
teins identified to date, one would expect a complex array of
molecules to regulate the effects of Daxx-NHE1 interactions.
Daxx plays a protective role in the nucleus (19). Therefore,
complete depletion ofDaxx is not beneficial to cells. Molecular
agents targeting the nucleocytoplasmic translocation of
Daxx should serve as efficient therapeutic tools. Leptomycin
B, an inhibitor of exportin-1, which transports Daxx from
the nucleus, exhibited a protective potential against ische-
mic injury (19), supporting this theory. Alternatively, mole-
cules disrupting Daxx-NHE1 interactions may have novel
therapeutic purposes, including use as effective anti-isch-
emic agents.
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